Adverum Biotechnologies Inc
NASDAQ:ADVM
Adverum Biotechnologies Inc
NASDAQ:ADVM
Price:
4.36
USD
Market Cap:
$96.3m
Balance Sheet
Balance Sheet Decomposition
Adverum Biotechnologies Inc
Adverum Biotechnologies Inc
Balance Sheet Decomposition is not available for
Adverum Biotechnologies Inc
Adverum Biotechnologies Inc
Balance Sheet
Adverum Biotechnologies Inc
Adverum Biotechnologies Inc
Currency: USD
| Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Cash & Cash Equivalents |
0
|
1
|
159
|
221
|
222
|
71
|
155
|
66
|
62
|
34
|
68
|
75
|
61
|
|
| Cash Equivalents |
0
|
1
|
159
|
221
|
222
|
71
|
155
|
66
|
62
|
34
|
68
|
75
|
61
|
|
| Short-Term Investments |
0
|
0
|
0
|
38
|
0
|
120
|
50
|
100
|
367
|
271
|
117
|
22
|
65
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
6
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
1
|
1
|
2
|
3
|
4
|
10
|
5
|
6
|
5
|
6
|
6
|
|
| Total Current Assets |
0
|
1
|
160
|
261
|
225
|
194
|
209
|
176
|
434
|
317
|
191
|
103
|
131
|
|
| PP&E Net |
0
|
0
|
1
|
3
|
4
|
3
|
4
|
46
|
47
|
119
|
114
|
67
|
45
|
|
| PP&E Gross |
0
|
0
|
1
|
3
|
4
|
3
|
4
|
46
|
47
|
119
|
114
|
67
|
45
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
1
|
3
|
5
|
6
|
8
|
10
|
13
|
17
|
15
|
18
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
5
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
1
|
0
|
0
|
0
|
1
|
1
|
1
|
3
|
4
|
3
|
3
|
|
| Total Assets |
0
N/A
|
1
+181%
|
162
+14 822%
|
264
+63%
|
235
-11%
|
202
-14%
|
213
+6%
|
223
+4%
|
483
+117%
|
440
-9%
|
308
-30%
|
173
-44%
|
180
+4%
|
|
| Liabilities | ||||||||||||||
| Accounts Payable |
1
|
1
|
1
|
1
|
1
|
2
|
2
|
4
|
3
|
1
|
2
|
2
|
2
|
|
| Accrued Liabilities |
0
|
0
|
4
|
4
|
6
|
7
|
9
|
15
|
18
|
19
|
30
|
23
|
21
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
1
|
2
|
2
|
2
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
1
|
5
|
7
|
10
|
11
|
11
|
19
|
21
|
21
|
32
|
25
|
23
|
|
| Long-Term Debt |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
7
|
5
|
8
|
6
|
2
|
28
|
27
|
102
|
95
|
65
|
86
|
|
| Total Liabilities |
1
N/A
|
1
-6%
|
12
+853%
|
12
-6%
|
19
+62%
|
18
-6%
|
12
-31%
|
48
+287%
|
48
+1%
|
124
+156%
|
127
+3%
|
90
-29%
|
109
+22%
|
|
| Equity | ||||||||||||||
| Common Stock |
2
|
8
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
4
|
9
|
37
|
84
|
198
|
254
|
321
|
385
|
503
|
648
|
803
|
920
|
1 067
|
|
| Additional Paid In Capital |
0
|
1
|
186
|
337
|
414
|
439
|
523
|
561
|
937
|
965
|
986
|
1 004
|
1 138
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
1
|
2
|
0
|
0
|
|
| Total Equity |
1
N/A
|
0
+78%
|
149
N/A
|
253
+69%
|
216
-15%
|
184
-15%
|
201
+9%
|
175
-13%
|
434
+148%
|
316
-27%
|
182
-43%
|
83
-54%
|
71
-15%
|
|
| Total Liabilities & Equity |
0
N/A
|
1
+181%
|
162
+14 822%
|
264
+63%
|
235
-11%
|
202
-14%
|
213
+6%
|
223
+4%
|
483
+117%
|
440
-9%
|
308
-30%
|
173
-44%
|
180
+4%
|
|
| Shares Outstanding | ||||||||||||||
| Common Shares Outstanding |
2
|
2
|
2
|
3
|
4
|
5
|
6
|
7
|
10
|
10
|
10
|
10
|
21
|
|
Switch to:
Switch to:
See Also
Discover More
